Grants and Contributions

The specific objectives of this funding opportunity are to:

• Inform best practices for the operation of safer supply interventions and supervised consumption sites
• Address pressing evidence needs of decision makers and knowledge users in the area of harm reduction interventions, taking into consideration the impact of the COVID-19 pandemic and the local context
• Consider the impact of the local context and other factors, such as biological and social determinants (e.g., sex, gender, age, housing status and income, etc.) and sub-populations (e.g., those with severe opioid use disorder, youth, Indigenous peoples, rural, inner-urban, etc.), on the interventions
• Identify considerations for further evaluation activities of harm reduction interventions, including insights and generalizable knowledge regarding implementation processes, barriers, and facilitators
• Advance evidence-based practices through knowledge dissemination activities
• Foster cross-disciplinary collaboration and bilateral interaction with decision makers in order to directly inform drug policy

The specific objectives of this funding opportunity are to:

• Inform best practices for the operation of safer supply interventions and supervised consumption sites
• Address pressing evidence needs of decision makers and knowledge users in the area of harm reduction interventions, taking into consideration the impact of the COVID-19 pandemic and the local context
• Consider the impact of the local context and other factors, such as biological and social determinants (e.g., sex, gender, age, housing status and income, etc.) and sub-populations (e.g., those with severe opioid use disorder, youth, Indigenous peoples, rural, inner-urban, etc.), on the interventions
• Identify considerations for further evaluation activities of harm reduction interventions, including insights and generalizable knowledge regarding implementation processes, barriers, and facilitators
• Advance evidence-based practices through knowledge dissemination activities
• Foster cross-disciplinary collaboration and bilateral interaction with decision makers in order to directly inform drug policy

The specific objectives of this funding opportunity are to promote:

• partnerships between Canadian and Japanese investigators in fields of biomedical and health research related to advancing epigenetic technologies
• the exchange of scientists, particularly early career scientists
• knowledge or methodology exchange
• complementary access to facilities / resources / equipment
• stronger opportunities for collaborative research and catalyse further synergy

The objectives of this opportunity are to:
• Put into practice proper ethical framework and technical infrastructure to enable genomic and phenotypic data access across borders;
• Establish connection between rare disease databases across borders;
• Demonstrate the utility of establishing such a federated database systems;
• Integrate the Global Alliance for Genomics in Health data access and sharing standards;
• Integrate FAIR principles (Findable, Accessible, Interoperable, Reusable).

The specific objective of this funding opportunity is:

To harness the power of new technologies and interventions to prevent the onset of cancer and/or reduce its severity though early detection when the disease is at its most treatable, including the early detection of recurrence and metastatic spread.

The Vanier CGS program aims to attract and retain world-class doctoral students and establish Canada as a global centre of excellence in research and higher learning by supporting students who demonstrate a high standard of scholarly achievement in graduate studies in the social sciences and humanities, natural sciences and engineering, and health; as well as leadership skills.

The Canada Graduate Scholarships-Master’s (CGS M) Program helps develop research skills and assist in the training of highly qualified personnel by supporting students who demonstrate a high standard of achievement in undergraduate and early graduate studies.

The specific objective of this funding opportunity is:

To harness the power of new technologies and interventions to prevent the onset of cancer and/or reduce its severity though early detection when the disease is at its most treatable, including the early detection of recurrence and metastatic spread.

The Vanier CGS program aims to attract and retain world-class doctoral students and establish Canada as a global centre of excellence in research and higher learning by supporting students who demonstrate a high standard of scholarly achievement in graduate studies in the social sciences and humanities, natural sciences and engineering, and health; as well as leadership skills.

The specific objectives of this funding opportunity are:
• to support research and development with a considerable economic and societal impact that:
- focuses on prevention, reversal or remission of type 2 diabetes or pre-diabetes;
- improves the quality of life for individuals with type 2 diabetes and their families;
- leads to sustainable collaborations between Dutch and Canadian type 2 diabetes researchers and Canadian type 2 diabetes researchers and for-profit private parties and other private parties.